> the thing is while something is better than nothing, new drug development is critical

> there is absolutely no cure for certain types of long-covid and me-cfs right now

> no repurposing any drug is going to cure it, they've tried everything after six years

Then repurposing should free up resources for new drug development for those conditions that it can't address.

Sounds like a win-win, unless the goal is somehow not to most efficiently allocate resources to maximize health outcomes. But at least in the US, that's clearly not the goal.